Mediwound deploys nexobrid® for emergency supply

Yavne, israel, oct. 09, 2023 (globe newswire) -- mediwound ltd. (nasdaq: mdwd), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, addresses emergency demand for nexobrid to treat the mass of burn casualties, inflicted by the war in israel.
MDWD Ratings Summary
MDWD Quant Ranking